Bridgewater Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Bridgewater Advisors's ELV Position: Q1 2026 in Review
Bridgewater Advisors reduced its Elevance Health (ELV) stake by 11% in Q1 2026, selling an estimated $21K and leaving 528 shares worth $211K. The position accounts for 0.01% of the portfolio, ranked #438.
Bridgewater Advisors first reported a position in ELV in Q1 2025 and has held it in 4 quarters since. The position peaked at $237K in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Bridgewater Advisors held 528 shares of Elevance Health worth $211K as of Q1 2026.
- Bridgewater Advisors sold 64 Elevance Health shares in Q1 2026, an estimated $21K.
- Elevance Health made up 0.01% of Bridgewater Advisors's portfolio in Q1 2026, its #438 holding.
- Bridgewater Advisors first reported a position in Elevance Health in Q1 2025 and has held it in 4 quarters since.
- Bridgewater Advisors's Elevance Health position peaked at $237K in Q1 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Bridgewater Advisors's 13F filing for Q1 2026, filed 14 May 2026.